Welcome
Faculty
Frederick Beddingfield,
   M.D., Ph.D.
Richard G. Bennett, M.D.
Keith Carlson, M.D.
Marc Chalet, M.D.
Melvin Chiu, M.D.
Jonathan Cotliar, M.D.
Ronald Cotliar, M.D.
Joseph Greco, M.D.
Miguel Gutierrez, M.D.
Jennifer Cecelia Haley, M.D.
Christopher Ho, M.D.
Malcolm Ke, M.D.
Christina Kim, M.D.
Jenny Kim, M.D., Ph.D.
Stephan Krutzik, Ph.D.
Gary P. Lask, M.D.
Delphine Lee, M.D., Ph.D.
Patrick K. Lee, M.D.
Roger Lo, M.D., Ph.D.
Lloyd Miller, M.D., Ph.D.
Robert L. Modlin, M.D.
Maria Teresa Ochoa, M.D.
Peter Allan Sieling, Ph.D.
Teresa Soriano, M.D.
Marie-Josee Thibault, M.D.
Eric Williams, M.D.
Lorraine Young, M.D.
Residency Program
Research
Patient Services
Support Our Mission
News and Announcements
Contact
Home
Frederick Coston Beddingfield, III, M.D., Ph.D.
Assistant Clinical Professor
Undergraduate Education North Carolina State University
Medical Education University of North Carolina at Chapel Hill
Internship Harbor-UCLA Medical Center,
Emergency Medicine
Residency Training Dermatology STAR program at UCLA
Combined Ph.D. in Policy Analysis at RAND Graduate School
Emergency Medicine, Harbor-UCLA Medical Center
Fellowship Training University of California, Los Angeles
Mohs Micrographic Surgery
Board Certification Dermatology,
Emergency Medicine
Clinical Interest Skin Cancer Surgery, Lasers, and Cosmetic Dermatology
Research Interest Clinical research trials, cost-effectiveness, and health
outcomes research; melanoma prevention and early
detection; new treatments for actinic keratosis, melanoma,
nonmelanoma skin cancer and psoriasis; cutaneous surgery
and laser therapy

Selected Publications

1. Beddingfield, FC III. Melanoma: A decision analysis to estimate the effectiveness and cost-effectiveness of screening and an analysis of the relevant epidemiology of the disease. UMI Dissertation Publishing and The RAND Corporation.

2. Beddingfield FC III. The melanoma epidemic. Resipsa loquitur. The Oncologist 2003, 8:459-465.

3. Kim J, Beddingfield FC III, Lask GP. Non-ablative resurfacing lasers. Principles and Practices in Cutaneous Laser Surgery. Ed. Kauvar ANB Marcel Dekker, Inc., New York, 2001.

4. Kim J, Beddingfield FC III, Lask GP. Non-ablative facial resurfacing. Operative Techniques in Oculoplastic, Orbital, and Reconstructive Surgery 3:55-57, 2000.

5. Menter A, Deborah Lew-Kaya D, Beddingfield FC III, Walker PS. A long-term, open-label study of the safety and efficacy of oral Tazarotene in moderate to very severe plaque psoriasis. American Academy of Dermatology. (Abstract) Washington, DC, February, 2004.

6. Papp KA, Beddingfield FC III, Manrow S, Walker PS. An open-label extension study evaluating the efficacy and safety of oral Tazarotene in plaque psoriasis. American Academy of Dermatology. (Abstract) Washington, DC, February, 2004.